TGFβ can act as a tumor suppressor and several tumors become resistant to TGFβ, as revealed by many studies that have shown the inactivation of both its receptors (Tβ-RI and Tβ-RII) in numerous human cancer cell lines, including colon and gastric cancer [6]. This evidence concerns the gene TGFB1 and cancer.